Literature DB >> 21225623

Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3.

Tze-Chen Hsieh1, Christina Wong, Dylan John Bennett, Joseph M Wu.   

Abstract

Resveratrol is a grape polyphenol with cancer preventative activities in tissue culture and animal model studies. Potential of resveratrol as a broad-based chemopreventive agent have been questioned by its limited bioavailability. The bioefficacy of resveratrol was compared with its derivatives, triacetyl-resveratrol (trans-3,5,4'-triacetylstilbene) and trimethoxy-resveratrol (trans-3,5,4'-trimethoxystilbene) in both estrogen receptor-α (ERα)-positive MCF-7 and ERα-negative MDA-MB-231 breast cancer cells. Binding to integrin αvβ3 and control of cell proliferation and p53 were chosen as targets for comparative analysis using an in silico and biochemical approach. Resveratrol and triacetyl-resveratrol interacted avidly and specifically with integrin αvβ3 through binding at the site targeted by the high affinity cyclic Arg-Gly-Asp (RGD) peptide. In contrast, binding of trimethoxy-resveratrol to this site was substantially less robust. Moreover, the different stilbenes also elicited diverse cellular and signaling responses in MCF-7 and MDA-MB-231 cells, as evidenced by analysis of colony formation, cell proliferation, cell cycle phase transition, the extent of phosphorylation of p53 at Ser15 and p53-inducible proteins, p21 and p53R2, respectively. Further, stilbene-elicited signaling cascade leading to p53 activation was examined in MCF-7 cells and results showed that resveratrol and triacetyl-resveratrol induced both ERK and p38 phosphorylation, whereas only marginal changes in state of phosphorylation in these two kinases were observed in trimethoxy-resveratrol-treated cells. Taken together, these results support that resveratrol and triacetyl-resveratrol regulate proliferation and gene expression in breast cancer cells by utilizing largely similar signaling molecules and pathways and cellular events, which appear quite distinct from those targeted by trimethoxy-resveratrol.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21225623     DOI: 10.1002/ijc.25930

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  3,4',5-trans-Trimethoxystilbene; a natural analogue of resveratrol with enhanced anticancer potency.

Authors:  Fahad S Aldawsari; Carlos A Velázquez-Martínez
Journal:  Invest New Drugs       Date:  2015-02-28       Impact factor: 3.850

Review 2.  Phytoestrogens and prevention of breast cancer: The contentious debate.

Authors:  Iqra Bilal; Avidyuti Chowdhury; Juliet Davidson; Saffron Whitehead
Journal:  World J Clin Oncol       Date:  2014-10-10

Review 3.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

4.  Resveratrol depletes mitochondrial DNA and inhibition of autophagy enhances resveratrol-induced caspase activation.

Authors:  Varun Prabhu; Pragya Srivastava; Neelu Yadav; Michael Amadori; Andrea Schneider; Athul Seshadri; Jason Pitarresi; Rachael Scott; Honghao Zhang; Shahriar Koochekpour; Raghu Gogada; Dhyan Chandra
Journal:  Mitochondrion       Date:  2012-10-23       Impact factor: 4.160

Review 5.  Small molecule hormone or hormone-like ligands of integrin αVβ3: implications for cancer cell behavior.

Authors:  Paul J Davis; Shaker A Mousa; Vivian Cody; Heng-Yuan Tang; Hung-Yun Lin
Journal:  Horm Cancer       Date:  2013-08-14       Impact factor: 3.869

6.  Functional/activity network (FAN) analysis of gene-phenotype connectivity liaised by grape polyphenol resveratrol.

Authors:  Tze-Chen Hsieh; Sheng-Tang Wu; Dylan John Bennett; Barbara B Doonan; Erxi Wu; Joseph M Wu
Journal:  Oncotarget       Date:  2016-06-21

Review 7.  Unraveling the Anticancer Effect of Curcumin and Resveratrol.

Authors:  Aline Renata Pavan; Gabriel Dalio Bernardes da Silva; Daniela Hartmann Jornada; Diego Eidy Chiba; Guilherme Felipe Dos Santos Fernandes; Chung Man Chin; Jean Leandro Dos Santos
Journal:  Nutrients       Date:  2016-11-10       Impact factor: 5.717

8.  Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition.

Authors:  Ly Quoc Trung; J Luis Espinoza; Akiyoshi Takami; Shinji Nakao
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

9.  Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2.

Authors:  Tze-chen Hsieh; Chia-Yi Lin; Dylan John Bennett; Erxi Wu; Joseph M Wu
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

Review 10.  The Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular Mechanisms.

Authors:  Ahmed Abdal Dayem; Hye Yeon Choi; Gwang-Mo Yang; Kyeongseok Kim; Subbroto Kumar Saha; Ssang-Goo Cho
Journal:  Nutrients       Date:  2016-09-21       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.